Dianthus Therapeutics DNTH
NASDAQ DNTH
$108.10 +0.25 (+0.23%)
As of: Sep 4, 2026 · 3:59 PM EDT

Dianthus Therapeutics (DNTH) EV to FCF (2018 - 2025)

Analysis

Dianthus Therapeutics (DNTH) EV to FCF (2018 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Dianthus Therapeutics 4.09 Bn 3.69 Bn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 -42.01
Jun 30, 2025 -14.29
Mar 31, 2025 -11.55
Dec 31, 2024 -14.67
Sep 30, 2024 -24.56
Jun 30, 2024 -27.43
Mar 31, 2024 -33.62
Dec 31, 2023 10.12
Sep 30, 2023 13.57
Jun 30, 2023 1.92
Mar 31, 2023 0.48
Dec 31, 2022 5.77
Sep 30, 2022 -1.26
Jun 30, 2022 4.06
Mar 31, 2022 -0.70
Dec 31, 2021 -5.32
Sep 30, 2021 -16.46
Jun 30, 2021 -26.00
Mar 31, 2021 -26.41
Dec 31, 2020 -16.61